Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Regenxbio Inc’s current trading price is -33.75% away from its 52-week high, while its distance from the 52-week low is 77.36%. The stock’s price range over this period has fluctuated between $5.03 and $13.48. The company, operating within the financial sector, had a trading volume of approximately 1.06 million for the day, which was noticeably higher than the average daily share volume of 0.91 million over the last 3 months.
The stock price for Regenxbio Inc (RGNX) currently stands at $8.93. The stock experienced a substantial increase in the last session, hitting $52.0 after starting at $8.93. The stock’s lowest price was $14.0 before closing at $8.1.
Regenxbio Inc experienced a rather steady stock market performance. The highest value in the past year was recorded at $13.48 on 09/17/24 and the lowest value was $5.03 on 04/09/25.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Regenxbio Inc (RGNX) has experienced a quarterly rise of 9.17% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 451.10M and boasts a workforce of 353 employees.
Regenxbio Inc: What Analysts Are Saying
As of right now, 6 analysts are rating Regenxbio Inc as a BUY, 5 of the polled analysts branded the stock as an OVERWEIGHT, 1 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 8.39, with a change in price of +0.57. Similarly, Regenxbio Inc recorded 978,528 in trading volume during the last 100 days, posting a change of +6.82%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for RGNX stands at 1.27. Similarly, the long-term debt-to-equity ratio is also 1.05.
RGNX Stock Stochastic Average
Today, Regenxbio Inc’s raw stochastic average for the past 50 days stands at 48.02%, indicating a decline from the raw stochastic average of the last 20 days, which was 80.20%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 41.29% and 23.90% respectively.
RGNX Stock Price Performance Analysis
Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. This year’s metric has recorded a Price decrease of -23.54%. However, over the past six months, we’ve seen a weaker performance of 21.83%. The price of RGNX fallen by 8.37% over the last 30 days. And in the last five days, it has surged by 8.51%.
